Tags
Results for: Mulvaney Lab
-
Article Item
Rare Disease Day brings worldwide attention to more than 7,000 rare diseases , articleVirginia Tech research into rare diseases — those that individually affect 200,000 or fewer but collectively touch 1 in 10 people in the U.S. — provides hope in identifying, treating, and supporting patients.
Date: Feb 28, 2024 -
Article Item
From healthy development to cancer treatments, Fralin Biomedical Research Institute scientists aim for impact , articleNew Seale Innovation Fund projects fuel a broad spectrum of research focused on cardiovascular disease, diabetes, cancer, stress, brain development, and more.
Date: Jan 29, 2024 -
Article Item
2023 marks a year of firsts for Translational Biology, Medicine, and Health Graduate Program , articleThe interdisciplinary program saw its first student assigned full-time to a Fralin Biomedical Research Institute lab in Washington, D.C., its first students from Nepal and Ghana in an internationally diverse incoming cohort, and its first student to be awarded a prestigious grant for future physician-scientists.
Date: Dec 15, 2023 -
Article Item
New cancer drug shows promise in targeting genetic weakness in tumors, Virginia Tech expert says , articleIn an invited review article in Cancer Discovery, a journal of the American Association for Cancer Research, Kathleen Mulvaney, assistant professor with the Fralin Biomedical Research Institute at VTC, talks about the potential of a new drug that has shown early promise in clinical trials for solid tumors by killing cancer cells that lack specific genes.
Date: Nov 01, 2023 -
Article Item
Common challenge, different strategies: Virginia Tech Cancer Research Alliance gathers broad mix of researchers and clinicians , articleThe second annual Virginia Tech Cancer Research Alliance retreat, hosted this year on the Children’s National Research & Innovation Campus, brought together scientists and physicians on the leading edge of developing innovative therapy types, fresh biological targets, and new technologies to take on cancer.
Date: Jun 21, 2023 -
Article Item
New cancer biologist targets ‘Achilles heel’ in deadly brain cancers , articleCancer biologist Kathleen Mulvaney joins the faculty of the Fralin Biomedical Research Institute at VTC on Oct. 1. Her lab will be in Washington, D.C., on the Children’s National Research & Innovation Campus as part of a partnership between Virginia Tech and Children’s National.
Date: Sep 27, 2022